GlaxoSmithKline | GSK - Market Capitalization

Stock Price
1,966.25
Daily Change
-46.75 -2.32%
Monthly
-11.67%
Yearly
30.65%
Q1 Forecast
1,988.76

GlaxoSmithKline reported GBP81.59B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Alcon AG USD 32.44B 1.36B Mar/2026
Almirall EUR 2.66B 102.29M Mar/2026
Amgen USD 176.25B 24.32B Dec/2025
argenx SE USD 38.95B 12.88B Mar/2026
AstraZeneca USD 288.15B 55.08B Dec/2025
Bayer EUR 36.89B 535.42M Mar/2026
Biogen USD 25.82B 5.28B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Fresenius EUR 28.24B 653.36M Mar/2026
Fresenius Medical Care EUR 11.68B 275.81M Mar/2026
Galapagos EUR 1.89B 49.73M Mar/2026
Genmab DKK 80.88B 7.82B Jun/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Glaxosmithkline GBP 86.88B 7.29B Sep/2025
GRIFOLS EUR 4.43B 3.06B Mar/2026
Hikma Pharmaceutical USD 2.92B 1.72B Mar/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.3B 6B Mar/2026
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
Novo Nordisk A/S DKK 1.45T 86.62B Dec/2025
Orion EUR 8.94B 243.74M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Philips EUR 22.38B 192.58M Dec/2025
Recordati EUR 10.15B 660.84M Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Smith & Nephew USD 3.97B 9.35B Mar/2026
UCB EUR 32.47B 4.91B Jun/2025